CC BY 4.0 · TH Open 2019; 03(02): e157-e164 DOI: 10.1055/s-0039-1692202
Original Article
Georg Thieme Verlag KG Stuttgart · New York
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients
with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
Maria Cristina Vedovati
1
Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy
,
Gianpaolo Reboldi
2
Department of Medicine, University of Perugia, Perugia, Italy
,
Giancarlo Agnelli
1
Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia, Italy
,
Paolo Verdecchia
3
Fondazione Umbra Cuore e Ipertensione-ONLUS, Ospedale S. Maria Della Misericordia,
Perugia, Italy
,
on Behalf of the Umbria-Fibrillazione Atriale Investigators› Institutsangaben